184 search results for: Pathophysiology

The Clinical Presentation of CSU is Heterogeneous
Dermatology
The Clinical Presentation of CSU is Heterogeneous
expert video

Dr Hawkes provides an overview of the distinctive characteristics of wheals and angioedema in clinical manifestation

View more
CSU is Unpredictable in its Course and Duration
Dermatology
CSU is Unpredictable in its Course and Duration
expert video

Dr. Hawkes highlights how Chronic Urticaria is a mast cell centric disease with moderate levels of spontaneous remission in patients.

View more
In Chronic Pruritic Skin Diseases, the Neuroimmune Axis Involves Dynamic Interactions Between Type 2 Inflammation and Sensory Nerves
Type 2 Inflammation
In Chronic Pruritic Skin Diseases, the Neuroimmune Axis Involves Dynamic Interactions Between Type 2 Inflammation and Sensory Nerves
expert video

In this soundbite video from the April 2025 ADVENT Forum in Lisbon, Portugal, Dr. Brian Kim describes the dynamic neuroimmune interactions in chronic pruritic skin diseases, emphasizing how type 2 cytokines and sensory nerves actively influence both itch perception and tissue inflammation.

View more
Immunological Drivers in CSU: Diverse Pathways to Mast Cell Activation
Dermatology
Immunological Drivers in CSU: Diverse Pathways to Mast Cell Activation
expert video

In this video from EADV 2025, Dr. Hawkes reviews the pathophysioogy of CSU with a focus on the role of type 2 inflammation

View more
KOL Video Interview – Dr Amy Paller
Dermatology
KOL Video Interview – Dr Amy Paller
expert video

In this exclusive video interview, Dr Amy Paller discusses two topics: 1) The importance of CCL17 (TARC) as a biomarker in pediatric patients with AD, and 2) How IL-4 and IL-13 contribute to skin barrier dysfunction in AD.

View more
Airway Hyperresponsiveness In Asthma Is Mainly Driven By  Components Of Type 2 Inflammation
Pulmonology
Airway Hyperresponsiveness In Asthma Is Mainly Driven By Components Of Type 2 Inflammation
interactivity

Examine underlying type 2 inflammation as a driver of airway hyperresponsiveness in patients with asthma.

View more
How do You Define Active Disease (CRSwNP) When Looking at the Nose With an Endoscope?
Rhinology
How do You Define Active Disease (CRSwNP) When Looking at the Nose With an Endoscope?
expert video

In this video clip from the EAACI 2024 symposium, Dr. Mullol discusses the challenge of defining active nasal disease using an endoscope.

View more
Can Chronic Rhinosinusitis With Nasal Polyps be Considered in Remission if the Patient has an Impaired Sense of Smell?
Rhinology
Can Chronic Rhinosinusitis With Nasal Polyps be Considered in Remission if the Patient has an Impaired Sense of Smell?
expert video

Dr. Backer discusses assessing remission in CRSwNP by evaluating the patient's sense of smell in this video clip from the EAACI 2024 symposium.

View more
What Drives Chronic Itch and the Itch-Scratch Cycle in Atopic Dermatitis?
Dermatology
What Drives Chronic Itch and the Itch-Scratch Cycle in Atopic Dermatitis?
videoanimation

Watch this short video to learn how type 2 inflammation, skin barrier dysfunction, and neurosensitization contribute to chronic itch and the itch-scratch cycle in atopic dermatitis

View more
Airway Hyperresponsiveness In Asthma Is Mainly Driven By Components Of Type 2 Inflammation
Pulmonology
Airway Hyperresponsiveness In Asthma Is Mainly Driven By Components Of Type 2 Inflammation
interactivity

Examine underlying type 2 inflammation as a driver of airway hyperresponsiveness in patients with asthma.

View more